Moderna stock had a banner year of sorts in 2021, as the company quickly scaled up production and distribution of its Covid-19 shot. Moderna's financial performance has also been great, with sales likely to grow over 13x year-over-year to more than $17 billion for 2021, with profits likely...
Moderna stock had a banner year of sorts in 2021, as the company quickly scaled up production and distribution of its Covid-19 shot. Moderna's financial performance has also been great, with sales likely to grow over 13x year-over-year to more than $17 billion for 2021, with profits likely...
Share this Article
Recommended